Kylie N Pillard, PA-C | |
10259 S Parker Rd Ste 200, Parker, CO 80134-9106 | |
(303) 805-2273 | |
Not Available |
Full Name | Kylie N Pillard |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 10259 S Parker Rd Ste 200, Parker, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053023598 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | PA.0007677 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kylie N Pillard, PA-C 10259 S Parker Rd Ste 200, Parker, CO 80134-9106 Ph: (303) 805-2273 | Kylie N Pillard, PA-C 10259 S Parker Rd Ste 200, Parker, CO 80134-9106 Ph: (303) 805-2273 |
News Archive
Cologuard stool DNA testing for colorectal cancer was found to be an accurate noninvasive screening option for Alaska Native people, a population with one of world's highest rates of colorectal cancer, concluded researchers from the Alaska Native Tribal Health Consortium and Mayo Clinic.
After treatment, 38.1 percent of patients with head and neck cancer who were employed at the time of cancer diagnosis reported discontinuing work because of their cancer and treatment, according to a report in the May issue of Archives of Otolaryngology-Head & Neck Surgery.
Infertility affects one in seven men of reproductive age worldwide. One idea for treating male sterility is spermatogonial stem cell (SSC) therapy.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSureâ„¢ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
› Verified 9 days ago
Mrs. Dawn R Woerner, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 9251 Twenty Mile Road, Parker, CO 80134 Phone: 970-225-5000 | |
Ms. Susan Lorraine Perrone, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 18924 Briargate Ln, #2b, Parker, CO 80134 Phone: 303-993-3725 | |
Mrs. Kristen Roda Genson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9949 S Oswego St, Ste 200, Parker, CO 80134 Phone: 303-925-4750 Fax: 303-925-4751 | |
Mary Lou Zimmermann, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 12230 Lioness Way, Parker, CO 80134 Phone: 303-644-9355 | |
Alexandria Hillesheim, Physician Assistant Medicare: Medicare Enrolled Practice Location: 8401 S Chambers Rd, Parker, CO 80134 Phone: 303-373-2008 | |
Nancy Arkis, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 19641 E Parker Square Dr, Parker, CO 80134 Phone: 303-840-3800 Fax: 303-840-8442 |